Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
about
Pharmacological interventions for non-ulcer dyspepsiaPharmacological interventions for non-ulcer dyspepsiaReview article: current treatment options and management of functional dyspepsia25 Years of Proton Pump Inhibitors: A Comprehensive Review.Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials.Effect of lansoprazole on the epigastric symptoms of functional dyspepsia (ELF study): A multicentre, prospective, randomized, double-blind, placebo-controlled clinical trial.Guidelines for the management of dyspepsia.Drug treatment of functional dyspepsia.Discriminant value of Rome III questionnaire in dyspeptic patients.Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.Asian consensus report on functional dyspepsia.Novel effects other than antisecretory action and off-label use of proton pump inhibitors.Proton pump inhibitors for functional dyspepsia.Long-term Ultrasonographic Follow-up Study of Gastric Motility in Patients with Functional Dyspepsia.An Evidence-Based Approach to the Management of Functional Dyspepsia Associated With Helicobacter pylori Infection.Therapeutic strategies for the treatment of dyspepsia.Review article: endpoints used in functional dyspepsia drug therapy trials.Current understanding of pathogenesis of functional dyspepsia.Proton-pump inhibitors for the treatment of functional dyspepsia.Why dyspepsia can occur without organic disease: pathogenesis and management of functional dyspepsia.Overlap of functional dyspepsia and GERD--diagnostic and treatment implications.An update on current pharmacotherapy options for dyspepsia.Eosinophils and mast cells as therapeutic targets in pediatric functional dyspepsiaFrom ischochymia to gastroparesis: proposed mechanisms and preferred management of dyspepsia over the centuries.Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia.Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan.Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial.ACG and CAG Clinical Guideline: Management of Dyspepsia.Should we still subcategorize helicobacter pylori-associated dyspepsia as functional disease?Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study.Epigastric pain syndrome accompanying pancreatic enzyme abnormalities was overlapped with early chronic pancreatitis using endosonography.Functional dyspepsia today.The Therapeutic and Diagnostic Value of 2-week High Dose Proton Pump Inhibitor Treatment in Overlapping Non-erosive Gastroesophageal Reflux Disease and Functional Dyspepsia Patients.Initial treatment with lansoprazole in young dyspeptic patients with negative urea breath test result: a randomized controlled trial with 12-month follow-up.Concomitant symptoms itemized in the Reflux Disease Questionnaire are associated with attenuated heartburn response to acid suppression.Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia.Commentary: rabeprazole improves symptoms in patients with functional dyspepsia in Japan - author's reply.Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.GABRA6 genetic polymorphism is associated with the risk of functional heartburn in Chinese.Asian consensus report on functional dyspepsia
P2860
Q24234257-D12215F0-7FF8-4EB6-9171-A9FC2D1D38AEQ24244245-559B450E-B959-47AA-B2D3-79E094097163Q26825651-CA0A423D-A40E-4287-A4CC-B5E81568B7D5Q28070003-C058EF09-D7C4-448B-8CC0-57B2AA6CF03BQ33298440-2F813246-CAD1-4AB6-810E-E2B9E2C676CBQ33695299-A367551C-F70C-4B44-BB93-2D1EA35FF1F1Q34453424-0E4A8797-516B-487D-97F3-3061148A567AQ34529448-DB49F124-C9C1-4290-A490-48179DE8AB5BQ34996019-AF4EE611-768D-4B98-B345-04651F5635A2Q35872064-CC11C32D-23E1-47F4-BABF-75F7121809E7Q35885912-FCDF1664-9976-43BB-98CB-5B5D8D6280C2Q36040679-DA66FE17-9AA9-4309-8AA6-900AE58DB1F2Q36300366-A5A44FB1-CD52-4FAE-B0B8-FC5E742D1FDEQ36492897-F24CC5AF-4EAA-4E8C-8312-0524A390C4A5Q37311724-E7B7E951-CD54-4199-A693-C9C80509616AQ37781371-33EDFBF8-8BE4-4D8C-BDF4-979F1ECEEFC9Q37827564-2B8D0F9D-B923-4E03-84C9-2F8984F6849DQ37858640-35E3B7E1-87F3-4989-BF0D-63F30998C0D3Q37902063-BC13C4B6-62B3-4B92-B55C-50E82A6FA057Q38024259-40705500-D79B-4CB7-A570-19736DEAE4BDQ38072281-254014EF-BEB7-46E0-BCDB-1A01E1A42D0EQ38115358-B6A055C6-DF0D-4CD4-AAA0-CABBF784334BQ38160491-AB2A2F5A-7DF8-4B0E-9FE3-FBC44B31F901Q38203217-BEF279BA-7AF1-468D-AFC0-75C279AC1764Q38240885-1BB5F75B-CA94-4EA8-9AF3-715796256023Q39221996-2AF387DD-A2CE-4881-B7AB-5150E72CEB47Q39349036-C84BFCEA-5BFF-441A-B430-93B50290159CQ39385451-3BCB6546-6FAA-423C-875A-EC766D85FB94Q39543042-59750D2A-F197-41C8-A72F-1AB6635FA24CQ39674010-C463BA83-4385-4D8C-9B9B-97D00A51C4FAQ41685496-A8B55D61-D3BC-4D1D-98AD-FE1C71F6079EQ41865426-51236052-B75C-4B63-9EA4-EE1B523FEA6FQ42548274-9B3030F9-DAF7-4660-A847-D6600EE0A272Q43650462-7275D83C-048D-4410-B57E-878AC9534F5EQ44030644-BE37F86A-107B-459D-86CF-CA78D32A1440Q44667066-9378227B-C297-47AC-968C-0E95B83FCB2FQ45042467-B7FD6E2C-35F2-446D-9B49-80152E645AFDQ53017567-67455EAD-52C8-41D1-B057-F0999C3A9489Q55043187-E234C662-E74F-4E00-9BB2-33D7B385E609Q57728314-C65E8BDC-77DE-4BF7-B4DA-4CB747E54260
P2860
Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Lansoprazole in the treatment ...... ed, placebo-controlled trials.
@ast
Lansoprazole in the treatment ...... ed, placebo-controlled trials.
@en
type
label
Lansoprazole in the treatment ...... ed, placebo-controlled trials.
@ast
Lansoprazole in the treatment ...... ed, placebo-controlled trials.
@en
prefLabel
Lansoprazole in the treatment ...... ed, placebo-controlled trials.
@ast
Lansoprazole in the treatment ...... ed, placebo-controlled trials.
@en
P2093
P1476
Lansoprazole in the treatment ...... ed, placebo-controlled trials.
@en
P2093
Betsy L Pilmer
David A Peura
David C Metz
Nancy Siepman
Nicholas J Talley
Thomas O G Kovacs
P304
P356
10.1016/J.AMJMED.2004.01.008
P407
P577
2004-06-01T00:00:00Z